In The News

J&J Talc Ruling Could Upend FDA Process, Ex-Head Tells SCOTUS

Bloomberg Law

04 Oct 2021

Morrison & Foerster was mentioned in Bloomberg Law’s coverage of a recent amicus brief filed by eight former Food and Drug Administration (FDA) officials in the U.S. Supreme Court in Johnson & Johnson v. Mississippi.

The officials argue that a Mississippi court decision allowing a consumer suit that challenges Johnson & John’s talc labeling threatens to “upend” the FDA’s vital decision-making process and could jeopardize public health. Read a copy of the amicus brief.

Joe Palmore, Stacy Cline Amin, Adam Sorensen, and Zachary Fuchs are representing the eight FDA officials.

Read the full article (subscription required).

Close
Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.